Orthodontics and botulinum toxin: Integrated care of a patient with bruxism and occlusal alteration by Dr Tomás A. Salazar et al.

• 1.Aragón Niño Í, Niño Aragón ML, Pampín Martínez MM, del Castillo Pardo de Vera JL, Cebrián Carretero JL. Tratamiento de la hipertrofia del músculo masetero con toxina botulínica. Consideraciones y manejo [Treatment of masseter muscle hypertrophy with botulinum toxin. Considerations and management]. Med Estética. 2022 Jun 15;71(2):45–50.
• 2.Kim NH, Chung JH, Park RH, Park JB. The use of botulinum toxin type A in aesthetic mandibular contouring. Plast Reconstr Surg. 2005 Mar;115(3):919–30.
• 3.González Magaña F, Miranda LM, Malagón Hidalgo H, González Amesquita V. Uso de toxina botulínica para tratamiento de la hipertrofía del músculo masetero [Use of botulinum toxin for treatment of hypertrophy of the masseter muscle]. Cir Plast Ibero-Latinoam. 2012 Jul–Sep;38(3):297–302.
• 4.Fedorowicz Z, van Zuuren EJ, Schoones J. Botulinum toxin for masseter hypertrophy. Cochrane Database Syst Rev. 2013 Sep 9;2013(9):CD007510.
• 5.Kim DH, Hong HS, Won SY, Kim HJ, Hu KS, Choi JH, Kim HJ. Intramuscular nerve distribution of the masseter muscle as a basis for botulinum toxin injection. J Craniofac Surg. 2010 Mar;21(2):588–91.